Celgene Director, Medical Affairs - International Markets / International Medical Affairs Disease Lead in Boudry, Switzerland

Description

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, ​quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.

Summary

This position is responsible for providing medium and long-term medical affairs input into the disease franchise strategy from an International perspective, through partnership with key Worldwide functions in the cross-functional disease team, affiliates and the Global disease team.

This position is responsible for supporting all activities in relation to design and delivery of a comprehensive program of educational activities, lectures and workshops in the International region. This position will collaborate and coordinate with the respective Medical Affairs functions in the Worldwide and Global headquarters to establish a rolling-year ahead of program planning.

This position will also cooperate within the cross-functional disease team (marketing and market access) in which is fully integrated to ensure one DT voice across countries, geographies and with the Worldwide and Global team(s).

As part of the International medical team, the position will be actively involved in cross-functional teams, planning and supporting this business. In addition, the position will be involved in managing a centralized KOL program.

As part of the oversight on the disease medium-term communication strategy, this function is also involved in the review of Celgene-supported studies intended for communication/publication (IITs and Cooperative Groups Studies) along with other Worldwide Medical Affairs and Clinical Development functions. As part of the International KOL management program, the function acts as central contact for cooperative groups in reference to the discussion/negotiation of new cooperative study proposals.

Key Responsibilities

  • The International Medical Affairs Disease Lead (MADL) works jointly with his/her peers in the disease team to establish a comprehensive International disease strategy and will be accountable for the delivery of International Medical Affairs strategic plans that forms a part of the overall International disease strategy. These peers include but are not limited to Clinical Research & Development, Drug Safety & Risk Management, Commercial, Pricing & Market Access, Regulatory Affairs and Research & Early Development.

  • An important part of the role of the International MADL is to be a strong Medical voice for International strategic and tactical disease planning and activities as well as also considering the compliance of these in the real world environment.

  • The MADL should support the respective Medical Affairs functions in the International Affiliate organizations and work closely with the relevant Worldwide HQ functions such as Medical Affairs Effectiveness (MAE), Medical Affairs Communication and Operations (MACO) and other functions listed above.

  • The MADL should develop and maintain a strong Medical Affairs program including a broad range of educational activities and ensure the central management of a Key Opinion Leader (KOL) plan for the disease area and be primary responsible for KOL development and organization and participation in International Advisory and Consultant Board meetings

  • The MADL should dedicate significant time within the Medical Affairs function and establish a very close collaboration with the Executive Medical Director International and Worldwide Medical Affairs to continuously improve Medical Affairs identity and expertise as well as the growth & development of the Medical Affairs Disease Team. The International MADL should participate and contribute to Medical Affairs functional specific activities and plans.

  • Alongside Commercial and P&MA the MADL will partner with New Product Planning Director to determine the priority markets and route to market (including both commercial and non commercial strategies) for new products.

  • Jointly with the Executive Medical Director International, the MADL is responsible reviewing IIT proposals considering Disease related research questions (DRQs) developed by Worldwide and Global teams.

  • The MADL should be actively involved in cross-functional team activity, strategic and budget planning, and other Medical Affairs functions supporting the business and represent International Medical Affairs. The MADL should maintain a close relationship to counterparts in other regional Medical Affairs organizations.

  • The MADL should ensure that all internal and external activities are planned and implemented according to highest compliance standards, this includes adhering to Celgene’s standards for interactions with Health Care Providers (HCPs) as well as being a pro-active contributor within the disease team to ensure that all plans and communications are in line with relevant compliance requirements

  • The MADL may act as Clinical Lead (CRP) for relevant Medical Affairs sponsored trials in the disease area (Ph IIIb, Phase IV, PASS etc) if no specific person is hired for this role.

  • The MADL should build and support a publication strategy for the International region with full integration in Worldwide and Global Publication Planning initiatives

  • Strategic support in developing health economic submissions as well as presentations to Committees in charge of developing treatment guidelines.

  • Budget planning and management

  • Other responsibilities as assigned

Skills/Knowledge Required

  • Strong scientific background including a medical/scientific degree (MD, MSc; PhD with doctorate preferred) and solid experience in a field relevant to pharmaceutical medical affairs

  • Experience in the Hematology and/or Oncology Therapeutic area

  • Experience in delivering medical affairs programes in International markets highly desirable

  • Experience in educational event design and planning

  • Awareness of international diversity of clinical practices and healthcare systems

  • Excellent relationships with KOLs, strong network building skills

  • Experience in clinical research, planning and implementing clinical study (protocols) including GCP knowledge as well as statistics and study design

  • Excellent communication and organization skills paired with high professional presence and credibility

  • Ability to effectively manage teams of peers

  • Strong team-player with interpersonal, public communication and negotiation skills

  • Creative thinking and innovation

  • Ability to represent Celgene at a high level of professional presence and credibility

  • Excellent Computer skills required, specifically Windows software, including Word, Excel and PowerPoint

  • Experience and knowledge of the drug development and/or commercialization process desired

  • Regular travel required

  • Strong identification with Celgene’s values and objectives

#LI-POST

COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE